This page shows the latest Targovax news and features for those working in and with pharma, biotech and healthcare.
the year, Targovax’ mesothelioma candidate ONCOS-102 with data due in 2019 and M032, an investigator-developed candidate in trials for glioblastoma.
Eva-Lotta Allan is an independent board director on biotech boards including publicly-listed Targovax.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Catherine Wheeler joins from Acetylon Pharmaceutical. Clinical stage company Targovax has added to its board of directors with the appointment of Catherine Wheeler. ... Patrick Vink, chairman of the board at Targovax, said: “We are delighted to welcome
Øystein Soug, chief executive officer of Targovax, said: “Bogenstaetter’s extensive experience of business development and corporate strategy in the biotech and pharma industry will be indispensable to us.”.
Dr Erik Digman Wiklund succeeds Oystein Soug. Targovax has appointed Dr Erik Digman Wiklund as its new chief financial officer from April this year, succeeding Oystein Soug who became the
Formerly chief financial officer, Soug joined Targovax in 2015 bringing over 20 years of financial management experience to the role. ... company. Jónas Einarsson, chairman of Targovax's board of directors, said: “We are delighted to announce the
Commenting on the appointments, Targovax's CEO Gunnar Gardemyr said: “I am pleased to welcome Anne-Kirst and Tina to our team. ... We look forward to the insight and wealth of experience that they bring to Targovax.”.
More from appointments
Approximately 5 fully matching, plus 0 partially matching documents found.
No results were found
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...